←
Miranda Kusters149 posts
Miranda Kusters avatar

Miranda Kusters

@MirandaKusters

MD, PhD, Colorectal surgeon @AmsterdamUMC

◷ Joined September 2018▧ 3 Photos and videos
JAMA Oncology avatar
⟳ Miranda Kusters retweeted
JAMA Oncology@JAMAOnc·24 Feb 2024

A 50% reduction in radiotherapy use for non-locally advanced rectal cancer did not compromise cancer-related outcomes at a national level. Optimizing clinical staging and surgery has enabled safe de-intensification of treatment. ja.ma/4bH74dO @mirandakusters @sannehazen

JAMA Oncology avatar
⟳ Miranda Kusters retweeted
JAMA Oncology@JAMAOnc·21 Dec 2023

A 50% reduction in radiotherapy use for non-locally advanced rectal cancer did not compromise cancer-related outcomes at a national level. Optimizing clinical staging and surgery has enabled safe de-intensification of treatment. ja.ma/478JaEz @mirandakusters @sannehazen

LaNoReC Study avatar
⟳ Miranda Kusters retweeted
LaNoReC Study@LanorecStudy·22 Nov 2023

On 21-11 Tania Sluckin obtained her doctoral degree by defending her thesis entitled "lateral lymph nodes in rectal cancer". This thesis stresses the importance of adequate treatment of lateral lymph nodes and the LaNoReC trial. Want to receive a PDF? Mail lanorec@amsterdamumc.nl

Post attachmentPost attachment
LaNoReC Study avatar
⟳ Miranda Kusters retweeted
LaNoReC Study@LanorecStudy·30 Oct 2023

Lateral lymph nodes during the @ESSOnews 142 conference! On Thursday 26th of October the prognostic implications of the number of lateral lymph nodes and their malignant features were discussed.

Post attachment
LaNoReC Study avatar
⟳ Miranda Kusters retweeted
LaNoReC Study@LanorecStudy·16 Jun 2023

The renewed Dutch delineation guideline has been approved by the Dutch GI radiotherapy association (LPRGE)! This guideline will guarantee uniform delineation and coverage of lateral lymph nodes in the LaNoReC study. Want to join the next online training? lanorec@amsterdamumc.nl

Post attachment
LaNoReC Study avatar
⟳ Miranda Kusters retweeted
LaNoReC Study@LanorecStudy·11 May 2023

Update @LaNoReCstudy: the study has become a registration study, not subject to ethical restrictions, open for ALL patients with enlarged (≥7.0mm) or intermediate (5.0-6.9mm) lateral nodes with ANY neoadjuvant treatment, with a new protocol. Keen to join? lanorec@amsterdamumc.nl

Post attachment